1Li X,Wilson JW.Increased vascularity of the bronchial mucosa in mild asthma.Am J Respir Crit Care Med,1997,156:229-233.
2Chetta A,Zanini A,Foresi A,et al.Vascular component of airway remodeling in asthma is reduced by high dose of fluticasone.Am J Respir Crit Care Med,2003,167:7551-757.
3Temelkovski J,Hogan SP,Shepherd DP,et al.An improved murine model of asthma:selectiv airway inflammation,epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen.Thorax,1998,53:849-856.
4Henderson WR Jr,Tang LO,Chu SJ,et al.A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model.Am J Respir Crit Care Med,2002,165:108-116.
5Honda K,Marquillies P,Capron M,et al.Peroxisome proliferator-activated receptor gamma is expressed in airways and inhibits features of airway remodeling in a asthma model.J Allergy Clin Immunol,2004,113:882-888.
6Nie M,Corbett L,Knox AJ,et al.Differential regulation of chemokine expression by peroxisome proliferator-activated receptor gamma agonists:interactions with glucocorticoids and beta2-agonists.J Biol Chem,2005,280:2550-2560.
7Vachier I,Chavis C,Majori M,et al.Effects of glucocorticoids on endogenous and transcellular metabolism of eicosanoids in asthma.J Allergy Clin Immunol,2001,107:824-831.
8McDonald DM. Angiogenesis and remodeling of airway vasculature in chronic inflammation[ J ]. Am J Respir Crit Care Med, 2001, 164( 10 Pt 2) :S39-45.
9Chetta A, Zanini A, Foresi A, Del Donno M, Castagnaro A, D' Ippolito R, et al. Vascular component of airway remodeling in asthma is reduced by high dose of fluticasone [ J ]. Am J Respir Crit Care Med, 2003,167(5) :751-757.
10Su X, Taniuchi N, Jin E, Fujiwara M, Zhang L, Ghazizadeh M, et al. Spatial and Phenotypic characterization of vascular remode ling in a mouse model of asthma[ J ]. Pathobiology, 2008,75 ( 1 ) : 42-56.
